Oblon hosted a webinar on "Using the Amgen-Sanofi Methodology to Identify the Historic Treatment of Patent Eligibility Issues: Today's 35 U.S.C. § 101 Issues."
The Amgen enablement decision illustrates the importance of performing thorough legal research on the case law on patent law issues. The webinar will focus primarily on the patent eligibility issues under 35 U.S.C. § 101. In the 19th century the courts addressed the patentability of abstract ideas and laws of nature. The courts considered decisions under British law in making their decision in some cases. The webinar will use these early cases to help clarify 35 U.S.C. § 101 which has been made complicated by conflicting Federal Circuit decisions and Alice two-step analysis.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
